Share Information

Other exchanges or trading platforms where Scancell Holdings plc securities are admitted or traded

Scancell Holdings securities are listed on AIM.

The number of securities in issue

The company has an issued share capital of 121,223,069 ordinary shares of 1p each, all of which are called up and fully paid.

Directors’ Share Options

The Company has granted the following options to current Directors of the Company.

Option holder
Option price per ordinary share
Number of ordinary shares under option
Last day of exercise period
Phil L’Huillier117p3,110,34419 February 2035
Lindy Durrant45p385,00031 January 2027
Lindy Durrant81.5p100,00030 April 2030
Lindy Durrant105p900,00030 January 2028
Lindy Durrant117p518,39019 February 2035
Lindy Durrant212.5p900,0009 September 2031
Jean-Michel Cosséry175p300,00020 April 2033
Susan Clement Davies175p100,00020 April 2033

 

There is a total of approximately 9,797,826 outstanding options granted to employees and others with a weighted average exercise price of approximately 126 pence.

Percentage of AIM securities not in public hands

As at 16 September 2025 the percentage of AIM securities not in public hands was: 43.53%

Restrictions on the transfer of securities

There are no restrictions on the transfer of shares.

Identity and percentage holdings of significant shareholders

As at 28 July 2026, the identity and percentage holdings of significant shareholders were:

 
Ordinary shares at 0.1p each
 
Number
Percentage
Redmile Group LLC297,188,36524.52%
Vulpes Life Science and Testudo Funds143,537,03711.84%
Pentwater Capital Management LP50,000,0004.12%

 

Director share interests

As at 21 October 2026, shares held by directors of the Company were as follows:

 
Ordinary shares at 1p each
 
Number
Percentage
Lindy Durrant206,9150.17%
Jean-Michel Cosséry45,4540.04%